Caricamento...

RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine

BACKGROUND: Gemcitabine has been widely used as a chemotherapeutic drug. However, drug resistance, short half-life and side effects seriously decrease its chemotherapeutic efficacy. PURPOSE: The object of preparing RGDV-gemcitabine was to prolong the half-life, to overcome drug resistance and to eli...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Nanomedicine
Autori principali: Liu, Wenchao, Mao, Yujia, Zhang, Xiaoyi, Wang, Yaonan, Wu, Jianhui, Zhao, Shurui, Peng, Shiqi, Zhao, Ming
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2019
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737205/
https://ncbi.nlm.nih.gov/pubmed/31686807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S212978
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !